Authors:
VANSTEEN BJ
VANWIJNGAARDEN I
RONKEN E
SOUDIJN W
Citation: Bj. Vansteen et al., FUNCTIONAL-CHARACTERISTICS OF A SERIES OF N4-SUBSTITUTED 1-(2,3-DIHYDRO-1,4-BENZODIOXIN-5-YL)PIPERAZINES AS 5-HT1A RECEPTOR LIGANDS - STRUCTURE-ACTIVITY-RELATIONSHIPS, Bioorganic & medicinal chemistry letters, 8(18), 1998, pp. 2457-2462
Authors:
MATHOT RAA
VANDERWENDEN EM
SOUDIJN W
BREIMER DD
IJZERMAN AP
DANHOF M
Citation: Raa. Mathot et al., PARTIAL AGONISM OF THE NONSELECTIVE ADENOSINE RECEPTOR AGONIST 8-BUTYLAMINOADENOSINE AT THE A(1) RECEPTOR IN-VIVO, The Journal of pharmacology and experimental therapeutics, 279(3), 1996, pp. 1439-1446
Authors:
MATHOT RAA
SOUDIJN W
BREIMER DD
IJZERMAN AP
DANHOF M
Citation: Raa. Mathot et al., PHARMACOKINETIC-HEMODYNAMIC RELATIONSHIPS OF 2-CHLOROADENOSINE AT ADENOSINE A(1) AND A(2A) RECEPTORS IN-VIVO, British Journal of Pharmacology, 118(2), 1996, pp. 369-377
Authors:
VANDERWENDEN EM
HARTOGWITTE HR
ROELEN HCPF
KUNZEL JKV
PIROVANO IM
MATHOT RAA
DANHOF M
VANAERSCHOT A
LIDAKS MJ
IJZERMAN AP
SOUDIJN W
Citation: Em. Vanderwenden et al., 8-SUBSTITUTED ADENOSINE AND THEOPHYLLINE-7-RIBOSIDE ANALOGS AS POTENTIAL PARTIAL AGONISTS FOR THE ADENOSINE A(1) RECEPTOR, European journal of pharmacology. Molecular pharmacology section, 290(3), 1995, pp. 189-199
Authors:
VANDERWENDEN EM
PRICE SL
APAYA RP
IJZERMAN AP
SOUDIJN W
Citation: Em. Vanderwenden et al., RELATIVE BINDING ORIENTATIONS OF ADENOSINE-A(1) RECEPTOR LIGANDS - A TEST-CASE FOR DISTRIBUTED MULTIPOLE ANALYSIS IN MEDICINAL CHEMISTRY, Journal of computer-aided molecular design, 9(1), 1995, pp. 44-54
Authors:
BEUKERS MW
KERKHOF CJM
VANRHEE MA
ARDANUY U
GURGEL C
WIDJAJA H
NICKEL P
IJZERMAN AP
SOUDIJN W
Citation: Mw. Beukers et al., SURAMIN ANALOGS, DIVALENT-CATIONS AND ATP-GAMMA-S AS INHIBITORS OF ECTO-ATPASE, Naunyn-Schmiedeberg's archives of pharmacology, 351(5), 1995, pp. 523-528
Authors:
MATHOT RAA
GUBBENSSTIBBE JM
SOUDIJN W
JACOBSON KA
IJZERMAN AP
DANHOF M
Citation: Raa. Mathot et al., QUANTIFICATION OF THE IN-VIVO POTENCY OF THE ADENOSINE A(2) RECEPTOR ANTAGONIST 8-(3-CHLOROSTYRYL)CAFFEINE, The Journal of pharmacology and experimental therapeutics, 275(1), 1995, pp. 245-253
Authors:
MATHOT RAA
VANDENAARSEN BCFM
SOUDIJN W
BREIMER DD
IJZERMAN AP
DANHOF M
Citation: Raa. Mathot et al., PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF THE CARDIOVASCULAR EFFECTS OF R-N-6-PHENYLISOPROPYLADENOSINE AND S-N-6-PHENYLISOPROPYLADENOSINEIN CONSCIOUS NORMOTENSIVE RATS, The Journal of pharmacology and experimental therapeutics, 273(1), 1995, pp. 405-414
Authors:
VANSTEEN BJ
VANWIJNGAARDEN I
TULP MTM
SOUDIJN W
Citation: Bj. Vansteen et al., A SERIES OF N4-IMIDOETHYL DERIVATIVES OF 1-(2,3-DIHYDRO-1,4-BENZODIOXIN-5-YL)PIPERAZINE AS 5-HT1A RECEPTOR LIGANDS - SYNTHESIS AND STRUCTURE-AFFINITY RELATIONSHIPS, Journal of medicinal chemistry, 38(21), 1995, pp. 4303-4308
Authors:
VANDERWENDEN EM
KUNZEL JKVD
MATHOT RAA
DANHOF M
IJZERMAN AP
SOUDIJN W
Citation: Em. Vanderwenden et al., RIBOSE-MODIFIED ADENOSINE-ANALOGS AS POTENTIAL PARTIAL AGONISTS FOR THE ADENOSINE RECEPTOR, Journal of medicinal chemistry, 38(20), 1995, pp. 4000-4006
Authors:
MATHOT RAA
VANDERWENDEN EM
SOUDIJN W
IJZERMAN AP
DANHOF M
Citation: Raa. Mathot et al., DEOXYRIBOSE ANALOGS OF N-6-CYCLOPENTYLADENOSINE (CPA) - PARTIAL AGONISTS AT THE ADENOSINE A(1) RECEPTOR IN-VIVO, British Journal of Pharmacology, 116(3), 1995, pp. 1957-1964
Authors:
MATHOT RAA
CLETON A
SOUDIJN W
IJZERMAN AP
DANHOF M
Citation: Raa. Mathot et al., PHARMACOKINETIC MODELING OF THE HEMODYNAMIC-EFFECTS OF THE A(2A) ADENOSINE RECEPTOR AGONIST CGS 21680C IN CONSCIOUS NORMOTENSIVE RATS, British Journal of Pharmacology, 114(4), 1995, pp. 761-768
Authors:
VANRHEE AM
VANDERHEIJDEN MPA
BEUKERS MW
IJZERMAN AP
SOUDIJN W
NICKEL P
Citation: Am. Vanrhee et al., NOVEL COMPETITIVE ANTAGONISTS FOR P-2 PURINOCEPTORS, European journal of pharmacology. Molecular pharmacology section, 268(1), 1994, pp. 1-7
Authors:
BEUKERS MW
KERKHOF CJM
IJZERMAN AP
SOUDIJN W
Citation: Mw. Beukers et al., NUCLEOSIDE TRANSPORT INHIBITION AND PLATELET-AGGREGATION IN HUMAN BLOOD - R75231 AND ITS ENANTIOMERS, DRAFLAZINE AND R88016, European journal of pharmacology. Molecular pharmacology section, 266(1), 1994, pp. 57-62
Authors:
VANDERBENT A
VANDENBRINK I
IJZERMAN AP
VANWIJNGAARDEN I
SOUDIJN W
Citation: A. Vanderbent et al., SYNTHESIS AND BIOLOGICAL EVALUATION OF LORGLUMIDE-LIKE HYBRID CHOLECYSTOKININ-A RECEPTOR ANTAGONISTS, Drug development research, 31(3), 1994, pp. 197-205
Authors:
MATHOT RAA
VANSCHAICK EA
LANGEMEIJER MWE
SOUDIJN W
BREIMER DD
IJZERMAN AP
DANHOF M
Citation: Raa. Mathot et al., PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIP OF THE CARDIOVASCULAR EFFECTS OF ADENOSINE A(1) RECEPTOR AGONIST N-6-CYCLOPENTYLADENOSINE IN THE RAT, The Journal of pharmacology and experimental therapeutics, 268(2), 1994, pp. 616-624
Authors:
MATHOT RAA
APPEL S
VANSCHAICK EA
SOUDIJN W
IJZERMAN AP
DANHOF M
Citation: Raa. Mathot et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF THE ADENOSINE A(1) AGONIST N-6-CYCLOPENTYLADENOSINE AND THE A(1) ANTAGONIST 8-CYCLOPENTYLTHEOPHYLLINE AND ITS APPLICATION IN A PHARMACOKINETIC STUDY IN RATS, Journal of chromatography. Biomedical applications, 620(1), 1993, pp. 113-120
Authors:
BEUKERS MW
PIROVANO IM
VANWEERT A
KERKHOF CJM
IJZERMAN AP
SOUDIJN W
Citation: Mw. Beukers et al., CHARACTERIZATION OF ECTO-ATPASE ON HUMAN BLOOD-CELLS - A PHYSIOLOGICAL-ROLE IN PLATELET-AGGREGATION, Biochemical pharmacology, 46(11), 1993, pp. 1959-1966
Authors:
VANDERBENT A
BLOMMAERT AGS
MELMAN CTM
IJZERMAN AP
VANWIJNGAARDEN I
SOUDIJN W
Citation: A. Vanderbent et al., HYBRID CHOLECYSTOKININ-A ANTAGONISTS BASED ON MOLECULAR MODELING OF LORGLUMIDE AND L-364,718, Journal of medicinal chemistry, 35(6), 1992, pp. 1042-1049